Author

Alison Kennedy

Wellcome/MRC Cambridge Stem Cell InstituteORCID 0000-0001-6681-3256Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ATAC-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:multiome· 1

Frequent Co-Authors

Adrian H. TayloriD· 1 shared Alexander Murison· 1 shared Alicia G. Aguilar-NavarroiD· 1 shared Andrew Jonathan CarriD· 1 shared Andy G. X. ZengiD· 1 shared Batchimeg UsukhbayariD· 1 shared Benjamin J. L. Kendrick· 1 shared Bilyana StoilovaiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adrian H. TaylorORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCell stem cellPeer-reviewedJun 24, 2024

Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging

Niels Asger Jakobsen, Sven Turkalj, Andy G. X. Zeng…·Paresh Vyas

This study identifies how DNMT3A and TET2 mutations in hematopoietic stem cells confer a selective advantage by reducing inflammation and aging effects.

165 citationstop 1%

humanscRNA-seq

𝕏 PostBluesky